Dr. Haas founded Orion Bionetworks in July 2012 and serves as its CEO and President. Orion Bionetworks was transformed to Cohen Veterans Bioscience in 2015 to specifically dedicate research to improving the detection and treatment of post-traumatic stress (PTS) and traumatic brain injury (TBI) and related co-morbidities so that the burden of these conditions may be lessened on service members, veterans, and their families.

Magali has over 15 years of pharmaceutical executive and clinical research experience, predominantly at Johnson & Johnson, where she assumed broad end-to-end development leadership roles in medical marketing, full clinical development, early development, and translational and biomarker sciences in psychiatry and neurology. She successfully filed NDAs in the US and Europe for risperidone indications in Autism, Adolescent Schizophrenia, Juvenile Bipolar Disorder and Conduct Disorders. She also led Development Teams evaluating compounds for Depression, Neuropathic Pain, Epilepsy, and Migraine Disorder.

She served 3 years as Chief Science and Technology Officer for One Mind for Research, a nonprofit organization launched in May 2012 by Patrick J Kennedy. She orchestrated the launch of One Mind’s seminal programs, Apollo, an informatics research portal and, Gemini, an international TBI/PTSD research program.

As an “intrapreneur” at J&J she established the first Neuroscience Translational Medicine & Integrative Solutions department, and co-founded the first Companion Diagnostics Center of Excellence as well as J&J’s Healthcare Innovation team. She serves on several advisory boards including Brain Canada, Prophase, Pear Therapeutics, PAASP and IMEC for nanoelectronics.

Magali earned her BS in bioengineering from the University of Pennsylvania, an MS in biomedical engineering from Rutgers University, New Jersey, and her MD PhD with distinction in neuroscience from Albert Einstein College of Medicine, New York.

 

Ajay Goel, PhD, Director of Epigenetics, Cancer Prevention, and Cancer Genomics at Baylor University Medical Center, has spent 20 years researching cancer and has been the lead author or contributor to over 150 scientific articles published in peer reviewed international journals. He is one of the world’s leading researchers on curcumin and colon cancer and is currently researching the prevention of gastrointestinal cancers using integrative and alternative approaches, including botanical products. Two of the primary botanicals he is investigating are curcumin (from turmeric) and boswellia.

Lothar Hirneise has been the president of Cancer 21 since 1997, an organisation for research and documentation of holistic cancer therapies. He is the author of the bestsellers: Chemotherapy heals cancer and the world is flat – and: The great cookbook and textbook of the oil protein diet.  2002 he got in Washington D.C. the NFAM (National Foundation for Alternative Medicine) Founders Award for Alternative and Complementary Medicine. Mr. Hirneise is also well known as the only student of the famous Dr. Johanna Budwig who is promoting the ORIGINAL Oil-Protein Diet especially for cancer patients. Together with Klaus Pertl he is the founder of the 3E-centre (www.3e-centre.com) and the Budwig Center (www.theoriginalbudwigcenter.com) in Germany and is teaching worldwide his 3E program, which is based on the analysis of case histories of thousands of people who survived late stage cancer.

Sue Hitzmann, MS, CST, NMT, is the creator of the MELT Method^®, a simple self-treatment technique that helps people get out and stay out of chronic pain. A nationally recognized educator, manual therapist, exercise physiologist, and founding member of the Fascial Research Society, Sue is the author of the New York Times bestselling book The MELT Method^®: A Breakthrough Self-Treatment System to Eliminate Chronic Pain, Erase the Signs of Aging, and Feel Fantastic in Just 10 Minutes a Day!, which has helped over 200,000 people lead a healthy, pain-free life.